6:04 AM ET
8-K
Shareholder Meeting
Oaktree Acquisition Corp. III Life Sciences Shareholder Meeting
Oaktree Acquisition Corp. III Life Sciences has postponed its extraordinary general meeting from October 16, 2026, to October 23, 2026. The meeting was called to vote on a proposal to extend the deadline for the company to complete an initial business combination. The postponement is intended to allow more time for the solicitation of shareholder proxies.